Recursion Pharmaceuticals has reported updated data from its ELUCIDATE & TUPELO trials, but the stock has failed to mount a ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the 12 Best Genomics Stocks to Invest In. Cathie Wood’s ARK Investment acquired 755,000 shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ...

Courses on the PGA Tour are loved for a variety of reasons. It might be the nostalgia of watching an event at the same venue each year, or a specific memory from a given year that makes golf fans have ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. Becoming a licensed ...

Hi! If you’re finding value in our Applied AI newsletter, I encourage you to consider subscribing to The Information. It ...

David Foster Wallace’s novel, in all its immensity, became the subject of sanctification and then scorn. But the work rewards ...

On a Tuesday at the end of last semester, I asked my first-year writing class how they were using AI in their courses. One of my strongest students raised her hand. She admitted, ...

Spaceship hosting offers low prices and decent performance, though it has a few quirks.

Tempus AI's diagnostics segment shows strong pricing power, with Oncology ASP rising from $1,630 to over $2,200. Read why TEM ...

TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) — Partners Value Investments L.P. (the “Partnership”) (TSX VENTURE: PVF) announced today that it has received approval from the TSX Venture Exchange (the ...